April 27, 2020 / 12:32 PM / a month ago

BRIEF-Mateon Therapeutics Submitted Application To FDA To Study Investigational Drug For Treatment Of Covid-19

April 27 (Reuters) - Mateon Therapeutics Inc:

* MATEON THERAPEUTICS - SUBMITTED IND APPLICATION TO U.S. FDA TO STUDY ITS INVESTIGATIONAL DRUG, OT-101, FOR TREATMENT OF COVID-19 PANDEMIC

* MATEON THERAPEUTICS - PROPOSED RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY INTENDED TO EVALUATE SAFETY, EFFICACY OF OT-101 IN ADULT PATIENTS HOSPITALIZED WITH COVID-19 & PNEUMONIA IN U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below